Clinical Trial Update: Raltegravir Insulin Sensitivity Study [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase 1 study evaluating insulin sensitivity in participants treated with raltegravir for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infections | Phase 1 | Status: COMPLETED